Radiology AI company Zebra Medical names new CEO, eyes expansion
Imaging analytics startup Zebra Medical Vision announced Jan. 14 that it’s hiring a new chief executive as it works to expand the company’s footprint in North America.
Ohad Arazi will assume the role of CEO at the Israel-based vendor on March 1, replacing co-founder Eyal Gura, who will remain as chairman of Zebra’s board. Arazi has a background in radiology and health IT, with stints at McKesson Technology Solutions and Change Healthcare, according to an announcement.
Limitless potential in radiology-related AI drew him to the firm, he said this week.
“The opportunity to harness the full breath of data encompassed within medical images is massive, with artificial intelligence and machine learning serving as the keys to unlock this potential,” Arazi said in a company blog. “This includes opportunities for AI to improve access to imaging in areas that are underserved by radiologists, to automatically detect under-diagnosed conditions, and to support discovery and development of novel drugs and medical devices.”
Arazi added that he sees Zebra Medical as one of the “founders of the AI movement in medical imaging,” and believes this segment of medicine is “rapidly moving out of the hype stage.”
The company now has four Food and Drug Administration-cleared AI offerings in the states and has raised about $52 million in funding to date.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.